Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non-Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,652
Stocks News & Analysis
stocks
Alibaba fair value increases by 49%
stocks
A 5-Star US stock to buy with a near-5% yield
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,164.60 | 9.20 | 0.10% |
CAC 40 | 7,880.87 | 10.19 | 0.13% |
DAX 40 | 23,745.06 | 5.59 | 0.02% |
Dow JONES (US) | 46,316.07 | 68.78 | 0.15% |
FTSE 100 | 9,299.84 | 15.01 | 0.16% |
HKSE | 26,622.88 | 494.68 | 1.89% |
NASDAQ | 22,591.15 | 107.09 | 0.48% |
Nikkei 225 | 44,910.57 | 133.18 | -0.30% |
NZX 50 Index | 13,157.68 | 25.12 | 0.19% |
S&P 500 | 6,661.21 | 17.51 | 0.26% |
S&P/ASX 200 | 8,880.40 | 11.10 | 0.13% |
SSE Composite Index | 3,862.53 | 34.43 | 0.90% |